Kidney Function and Cognitive Impairment in US Adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Overview
Authors
Affiliations
Background: The association between kidney function and cognitive impairment has not been assessed in a national sample with a wide spectrum of kidney disease severity.
Study Design: Cross-sectional.
Setting & Participants: 23,405 participants (mean age, 64.9 +/- 9.6 years) with baseline measurements of creatinine and cognitive function participating in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study, a study of stroke risk factors in a large national sample.
Predictor: Estimated glomerular filtration rate (eGFR).
Outcome: Cognitive impairment.
Measurements: Chronic kidney disease (CKD) was defined as eGFR less than 60 mL/min/1.73 m(2). Kidney function was analyzed in 10-mL/min/1.73 m(2) increments in those with CKD, and in exploratory analyses, across the range of kidney function. Cognitive function was assessed using the 6-Item Screener, and participants with a score of 4 or less were considered to have cognitive impairment.
Results: CKD was associated with an increased prevalence of cognitive impairment independent of confounding factors (odds ratio, 1.23; 95% confidence interval, 1.06 to 1.43). In patients with CKD, each 10-mL/min/1.73 m(2) decrease in eGFR less than 60 mL/min/1.73 m(2) was associated with an 11% increased prevalence of impairment (odds ratio, 1.11; 95% confidence interval, 1.04 to 1.19). Exploratory analyses showed a nonlinear association between eGFR and prevalence of cognitive impairment, with a significant increased prevalence of impairment in those with eGFR less than 50 and 100 mL/min/1.73 m(2) or greater.
Limitations: Longitudinal measures of cognitive function were not available.
Conclusions: In US adults, lower levels of kidney function are associated with an increased prevalence of cognitive impairment. The prevalence of impairment appears to increase early in the course of kidney disease; therefore, screening for impairment should be considered in all adults with CKD.
Kidney function and cognitive impairment: a systematic review and meta-analysis.
Pei X, Bakerally N, Wang Z, Bo Y, Ma Y, Yong Z Ren Fail. 2025; 47(1):2463565.
PMID: 40037396 PMC: 11881663. DOI: 10.1080/0886022X.2025.2463565.
Kamin Mukaz D, Tison S, Long D, Carson A, Hunt K, Judd S J Clin Lab Anal. 2025; 39(4):e25121.
PMID: 39921333 PMC: 11848213. DOI: 10.1002/jcla.25121.
Current Status of the Cognitive Impairment in Chronic Kidney Disease.
Otobe Y Phys Ther Res. 2025; 27(3):115-120.
PMID: 39866390 PMC: 11756563. DOI: 10.1298/ptr.R0033.
Kidney Function, Cognitive Impairment, and Trajectories: A Longitudinal Biracial Study.
Cheung K, Arce Renteria M, Callas P, Kurella Tamura M, Gutierrez O, Cushman M J Gen Intern Med. 2025; .
PMID: 39843671 DOI: 10.1007/s11606-025-09366-0.
Syafrita Y, Harun H, Susanti R, Indra S Innov Clin Neurosci. 2025; 21(10):44-47.
PMID: 39790902 PMC: 11709437.